The role of the anti-ageing protein Klotho in vascular physiology and pathophysiology.
Klotho is an anti-ageing protein that functions in many pathways that govern ageing, like regulation of phosphate homeostasis, insulin signaling, and Wnt signaling. Klotho expression levels and levels in blood decline during ageing. The vascular phenotype of Klotho deficiency features medial calcification, intima hyperplasia, endothelial dysfunction, arterial stiffening, hypertension, and impaired angiogenesis and vasculogenesis, with characteristics similar to aged human arteries. Klotho-deficient phenotypes can be prevented and rescued by Klotho gene expression or protein supplementation. High phosphate levels are likely to be directly pathogenic and are a prerequisite for medial calcification, but more important determinants are pathways that regulate cellular senescence, suggesting that deficiency of Klotho renders cells susceptible to phosphate toxicity. Overexpression of Klotho is shown to ameliorate medial calcification, endothelial dysfunction, and hypertension. Endogenous vascular Klotho expression is a controversial subject and, currently, no compelling evidence exists that supports the existence of vascular membrane-bound Klotho expression, as expressed in kidney. In vitro, Klotho has been shown to decrease oxidative stress and apoptosis in both SMCs and ECs, to reduce SMC calcification, to maintain the contractile SMC phenotype, and to prevent μ-calpain overactivation in ECs. Klotho has many protective effects with regard to the vasculature and constitutes a very promising therapeutic target. The purpose of this review is to explore the etiology of the vascular phenotype of Klotho deficiency and the therapeutic potential of Klotho in vascular disease.
Department of Pathology and Medical Biology (Division of Pathology), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Rik
R
Mencke
Department of Pathology and Medical Biology (Division of Pathology), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Electronic address: j.l.hillebrands@umcg.nl.
Jan-Luuk
JL
Hillebrands
Department of Pathology and Medical Biology (Division of Pathology), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
D000368:Aged; D000375:Aging / Q000502:physiology*; D001808:Blood Vessels / Q000502:physiology / Q000503:physiopathology; D055808:Drug Discovery; D005966:Glucuronidase / Q000172:deficiency / Q000378:metabolism; D006801:Humans; D000090265:Klotho Proteins; D009131:Muscle, Smooth, Vascular / Q000502:physiology / Q000503:physiopathology; D014652:Vascular Diseases / Q000378:metabolism / Q000503:physiopathology / Q000517:prevention & control
D005966:Glucuronidase; D000090265:Klotho Proteins
Ageing; Endothelial cells; Endothelial dysfunction; Klotho; Smooth muscle cells; Vascular calcification